29.10.2014 • NewsBayern KapitalCunesoftFinanzierung

High Tech Gründerfonds (HTGF) and Bayern Kapital invest in Cunesoft GmbH

Cunesoft GmbH, a cloud software provider for regulatory document and submission management, specialized in the pharmaceutical industry, announced hat it successfully closed an investment round with High-Tech Gründerfonds and Bayern Kapital. The funds will be used to further internationalize sales activities as well as to expand the software's capabilities.

Within the pharmaceutical industry, the filing of the drug submission dossier involves critical and regulated processes. As the first European-based provider of a SaaS (Software as a Service) model Cunesoft now provides an integrated online regulatory software solution for effective submission document preparation as well as eCTD (electronic Common Technical Document) drug submission publishing.

"We are excited about having won High-Tech Gründerfonds and Bayern Kapital as investors", say Daniel Koppers and Rainer Schwarz. "The funding will allow us to include important collaborative features into the software. For example, a direct connection of the Cunesoft online platform with authority submission portals will be completed. Another area of functional expansion is the secure collaboration and sharing of our customers documents and dossiers with their external suppliers and customers."

 

Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

most read

Photo
24.01.2025 • News

And the Winners are: Cynio, EnaDyne and Green Li-ion

The CHEManager Innovation Pitch, the start-up promotion initiative of CHEManager and CHEManager International, has given more than 100 start-ups from over 15 countries the opportunity to present their innovative ideas, products and technologies to a broad target group since its launch in 2019.

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.